CLINICAL_TRIALS trial_result · 2017-04-28

Clinical Trial Update: PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1 [Phase 3]

Regeneron's Phase 3 preventive trial for urate-lowering drug–induced gout exacerbations in intercritical gout has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Regeneron Pharmaceuticals | Conditions: Intercritical Gout | Phase 3 | Status: COMPLETED | Results posted: 2017-04-28